Elissa Ozanne, PhD

Associate Professor, Department of Surgery and Institute for Health Policy Studies, UCSF

elissa.ozanne@ucsfmedctr.org

Phone: (415) 476-1942 (voice)
Box 0936, UCSF
San Francisco, CA 94143-0936

View on UCSF Profiles

Education

Stanford University, Stanford, CA, B.S., 1997, Biological Sciences
Stanford University, Stanford, CA, M.S., 1998, Engineering Economic Systems
Stanford University, Stanford, CA, Ph.D., 2003, Management Science and Engineering

Professional Experience

• 1996-1997
  Research Associate, Entelos, Menlo Park, CA
• 1998-1999
  Decision Services Associate, Pharsight, Mountain View, CA
• 2000-2002
  Research Associate, University of California San Francisco Medical Center, San Francisco, CA
• 2003
  Post-Doctoral Research Fellow, Department of Surgery, University of California San Francisco Medical Center, San Francisco, CA
• 2003-2005
  Post-Doctoral Research Fellow, National Cancer Institute, Program in Cancer Outcomes Research Training, Massachusetts General Hospital, Institute for Technology Assessment
• 2005-2009
  Instructor, Harvard Medical School, Boston, MA
• 2005-2011
  Senior Scientist, The Institute for Technology Assessment, Massachusetts General Hospital, Boston, MA
• 2007
  Fellowship, Summer Institute in Informed Patient Choice, Dartmouth Hitchcock Medical Center
• 2008
  Fellowship, Summer Institute in Informed Patient Choice, Dartmouth Hitchcock Medical Center (Lead Fellow)
• 2009
  Fellowship, Summer Institute in Informed Patient Choice, Dartmouth Hitchcock Medical Center
• 2009-2011
  Assistant Professor, Harvard Medical School, Boston, MA
• 2011-present
  Assistant Professor, University of California, San Francisco, CA
• 2012-present
  Associate Professor, University of California, San Francisco, CA

Honors & Awards

• 1998-1999
  Chief Teaching Assistantship, Decision Analysis Core, Stanford University
• 1999-2000
  Pharsight Corporation Research Fellowship
• 2000-2002
  Carol Franc Buck Breast Care Center Doctoral Research Fellowship, UCSF Medical Center
• 2007
  Eminent Scientist of the Year 2007, International Research Promotion Council

Selected Publications

1. Esserman L, Ozanne E, Van't Veer L. Will early detection for breast cancer ever work? Clin Chem. 2013 Jan; 59(1):190-3.
   View on PubMed
2. Ozanne EM, Drohan B, Bosinoff P, Semine A, Jellinek M, Cronin C, Millham F, Dowd D, Rourke T, Block C, Hughes KS. Which Risk Model to Use? Clinical Implications of the ACS MRI Screening Guidelines. Cancer Epidemiol Biomarkers Prev. 2013 Jan; 22(1):146-9.
   View on PubMed
3. Ozanne EM, O'Connell A, Bouzan C, Bosinoff P, Rourke T, Dowd D, Drohan B, Millham F, Griffin P, Halpern EF, Semine A, Hughes KS. Bias in the reporting of family history: implications for clinical care. J Genet Couns. 2012 Aug; 21(4):547-56.
   View on PubMed
4. Campbell S, Stowe K, Ozanne EM. Interprofessional practice and decision support: an organizational framework applied to a mental health setting. J Interprof Care. 2011 Nov; 25(6):423-7.
   View on PubMed
5. Lowry KP, Lee JM, Kong CY, McMahon PM, Gilmore ME, Cott Chubiz JE, Pisano ED, Gatsonis C, Ryan PD, Ozanne EM, Gazelle GS. Annual screening strategies in BRCA1 and BRCA2 gene mutation carriers: a comparative effectiveness analysis. Cancer. 2012 Apr 15; 118(8):2021-30.
   View on PubMed
6. Esserman LJ, Moore DH, Tsing PJ, Chu PW, Yau C, Ozanne E, Chung RE, Tandon VJ, Park JW, Baehner FL, Kreps S, Tutt AN, Gillett CE, Benz CC. Biologic markers determine both the risk and the timing of recurrence in breast cancer. Breast Cancer Res Treat. 2011 Sep; 129(2):607-16.
   View on PubMed
7. Ozanne EM, Shieh Y, Barnes J, Bouzan C, Hwang ES, Esserman LJ. Characterizing the impact of 25 years of DCIS treatment. Breast Cancer Res Treat. 2011 Aug; 129(1):165-73.
   View on PubMed
8. Lee JM, McMahon PM, Kong CY, Kopans DB, Ryan PD, Ozanne EM, Halpern EF, Gazelle GS. Cost-effectiveness of breast MR imaging and screen-film mammography for screening BRCA1 gene mutation carriers. Radiology. 2010 Mar; 254(3):793-800.
   View on PubMed
9. Ozanne EM, Wittenberg E, Garber JE, Weeks JC. Breast cancer prevention: patient decision making and risk communication in the high risk setting. Breast J. 2010 Jan-Feb; 16(1):38-47.
   View on PubMed
10. Drohan B, Ozanne EM, Hughes KS. Electronic health records and the management of women at high risk of hereditary breast and ovarian cancer. Breast J. 2009 Sep-Oct; 15 Suppl 1:S46-55.
    View on PubMed
11. Sepucha K, Ozanne EM. How to define and measure concordance between patients' preferences and medical treatments: A systematic review of approaches and recommendations for standardization. Patient Educ Couns. 2010 Jan; 78(1):12-23.
    View on PubMed
12. Ozanne EM, Partridge A, Moy B, Ellis KJ, Sepucha KR. Doctor-patient communication about advance directives in metastatic breast cancer. J Palliat Med. 2009 Jun; 12(6):547-53.
    View on PubMed
13. Sepucha KR, Ozanne EM, Partridge AH, Moy B. Is there a role for decision aids in advanced breast cancer? Med Decis Making. 2009 Jul-Aug; 29(4):475-82.
    View on PubMed
14. Braithwaite D, Tammemagi CM, Moore DH, Ozanne EM, Hiatt RA, Belkora J, West DW, Satariano WA, Liebman M, Esserman L. Hypertension is an independent predictor of survival disparity between African-American and white breast cancer patients. Int J Cancer. 2009 Mar 1; 124(5):1213-9.
    View on PubMed
15. Ozanne EM, Loberg A, Hughes S, Lawrence C, Drohan B, Semine A, Jellinek M, Cronin C, Milham F, Dowd D, Block C, Lockhart D, Sharko J, Grinstein G, Hughes KS. Identification and management of women at high risk for hereditary breast/ovarian cancer syndrome. Breast J. 2009 Mar-Apr; 15(2):155-62.
    View on PubMed
16. Hur C, Broughton DE, Kong CY, Ozanne EM, Richards EB, Truong T, Gazelle GS. Patient preferences for the chemoprevention of colorectal cancer. Dig Dis Sci. 2009 Oct; 54(10):2207-14.
    View on PubMed
17. Ozanne EM, Braithwaite D, Sepucha K, Moore D, Esserman L, Belkora J. Sensitivity to input variability of the Adjuvant! Online breast cancer prognostic model. J Clin Oncol. 2009 Jan 10; 27(2):214-9.
    View on PubMed
18. Pandharipande PV, Harisinghani MG, Ozanne EM, Specht MC, Hur C, Lee JM, Gazelle GS. Staging MR lymphangiography of the axilla for early breast cancer: cost-effectiveness analysis. AJR Am J Roentgenol. 2008 Nov; 191(5):1308-19.
    View on PubMed
19. Hur C, Broughton DE, Ozanne E, Yachimski P, Nishioka NS, Gazelle GS. Patient preferences for the chemoprevention of esophageal adenocarcinoma in Barrett's esophagus. Am J Gastroenterol. 2008 Oct; 103(10):2432-42.
    View on PubMed
20. Silvia KA, Ozanne EM, Sepucha KR. Implementing breast cancer decision aids in community sites: barriers and resources. Health Expect. 2008 Mar; 11(1):46-53.
    View on PubMed

View on UCSF Profiles